AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
KSH: retail turnover in November exceeded the same period of the previous year by 4.1 percent and the previous month by 0.6 percent
In November 2024, the volume of retail trade turnover increased…
Read more >NGM: Public confidence is apparently starting to return
The government is working to improve the economy so that…
Read more >Fidelity Outlook 2025: The US is ready for reflation
The Republicans’ landslide victory in the November election has significantly…
Read more >